Livent Corporation (NYSE:LTHM) does about 2.66M shares in volume on a normal day but saw 2913489 shares change hands in Tuesday trading. The company now has a market cap of 1.24B USD and an enterprise value of about $1.40B. Its current market price is $9.00, marking an increase of 6.13% compared to the previous close of $8.48. The 52 week high reached by this stock is $12.29 whilst the lowest price level in 52 weeks is $3.95. The script in recent trading has seen the stock touch a high of $9.04 and a low of $8.345.
Livent Corporation (LTHM) has a 20-day trading average at $7.68 and the current price is -26.77% off the 52-week high compared with 127.85% distance from its 52-week low. The 50-day simple moving average of the closing price is $6.90 and its 200-day simple moving average is $7.41. If we look at the stock’s price movements over the week, volatility stands at 7.43%, which decreases to 5.69% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 74.33 to suggest the stock is overbought.
12 analysts observing the Livent Corporation (LTHM) stock have set the 12-month price targets for the company’s shares at between $5.00 and $9.00. The consensus objective for the share price is $7.50, suggesting that the stock has a potential downside of -20.0% over the period. The median price target is -20.0% away from the current levels at $7.50.
FactSet Research has provided data showing that 12 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 1 advise that it is a overweight. 2 analysts have rated it as a buy and 8 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 26, 2020 when Raymond James initiated the stock to “Strong Buy” and issued a price target of $9. BMO Capital Markets upgraded the stock to “Market Perform” from Underperform on April 06, 2020 at a price target of . Goldman downgraded its price target at $9.50-$5.
The current price level is 18.86%, 31.37%, and 21.56% away from its SMA20, SMA50, and SMA200 respectively, with the LTHM price moving below the 50-day SMA on September 01. Livent Corporation (LTHM) stock is up 17.96% over the week and 39.75% over the past month. Its price is 5.26% year-to-date and 50.75% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of $0 below consensus estimates by -$0.02. The company’s next earnings report is expected on 11/09/2020, with forecasts estimating quarterly EPS at $0.01 and $0.07 for whole year. LTHM’s earnings per share are forecast to shrink by -83.30% this year and 242.90% over next year. Expected sales for next quarter are $82.64 million, which analysts say will come at $304.93 million for the current fiscal year and next year at $376.27 million. In addition, estimates put the company’s current quarterly revenue at an average of $69.76 million.
Its 12-month price target is $7.50. To reach the target analysts have set, the stock logically needs to shrink -20.0 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $5.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $9.00.
Outstanding shares total 146.20M with insiders holding 0.75% of the shares and institutional holders owning 104.82% of the company’s common stock. The company has a return on investment of 7.30% and return on equity of 2.90%. The price to earnings ratio (P/E ratio) amounts to 84.11 while the forward price to earnings ratio is 37.34. Price to book ratio is 2.30 and price to sales ratio is 4.02.
According to a U.S. Securities and Exchange Commission filing, iShares Core S&P Small Cap ETF has added its position in Livent Corporation (LTHM) to 9,099,966 shares, mirroring a recent increase by 0.36%. iShares Core S&P Small Cap ETF added 32508.0 shares of Livent Corporation common stock bringing its total worth to about $57.06 million at the end of recent close, SEC documents show. iShares Core S&P Small Cap ETF isn’t the only investment manager who changed stakes and is followed by Fidelity OTC Portfolio, which sold off 92336.0 shares to end up with 5,708,823 shares worth $35.79 million. Fidelity Balanced Fund raise their holdings by 11.06% in the company over the course of the most recent quarter. It now holds a 3.85% position in Livent Corporation thanks to 5.62 million shares amounting to $35.26 million.